Tirzepatide Weight Loss Review
Embody Tirzepatide Reviews 2026: Compounded Dual GLP-1/GIP $99/mo Yearly Plan
Biggest sale of the year, limited time only (Oct 27 – Dec 1): compounded tirzepatide at $99/month on the yearly plan (semaglutide $49/month), with no membership fee and free 1–2 day shipping.
- $99/mo yearly tirzepatide — one of the lowest we track ($119 monthly)
- Semaglutide $49/mo yearly ($69 monthly)
- Sale runs Oct 27 – Dec 1, limited time only
- Compounded tirzepatide — not an FDA-approved finished product
- No membership fee · free 1–2 day shipping
$99/mo yearly (semaglutide $49/mo)
Compounded medication · confirm current pricing at checkout
By Charly P. · Reviewed by Ved P. · Not a medical review
Updated August 2026 · Pricing last checked August 2026
- One of the lowest prices we track
- No membership fee
- Free 1–2 day shipping
- Clinician-reviewed prescriptions
Embody is running its biggest sale of the year through December 1: compounded tirzepatide at $99 a month on the yearly plan — close to the floor of the entire compounded telehealth market for the dual-agonist molecule.
About Embody's Tirzepatide Program
Embody is a cash-pay telehealth weight-loss platform built around aggressive medication pricing — semaglutide at $49/month and tirzepatide at $99/month on yearly plans ($69 and $119 monthly), with clinician review and fast free shipping folded into that single figure and no membership tier on top.
- Tirzepatide is the more capable and more expensive molecule everywhere it’s sold — a dual agonist acting on both the GIP and GLP-1 receptors rather than GLP-1 alone
- Embody’s pitch: you shouldn’t have to pay a heavy premium for it
- What’s not included: a coaching app or dedicated success manager — exactly why the sticker stays this low
For the platform as a whole, including the semaglutide side, see our full Embody GLP-1 program review.
Embody Tirzepatide at a Glance
| Program type | Cash-pay online GLP-1 program, 100% remote |
|---|---|
| Molecule reviewed here | Tirzepatide, a dual GIP and GLP-1 receptor agonist |
| Price | $99/month yearly plan (sale), $119/month monthly |
| Sale window | Tuesday, October 27 – Tuesday, December 1 |
| Semaglutide (for comparison) | $49/month yearly, $69/month monthly |
| Shipping | Free, typically 1-2 days |
| Dosing | One self-administered subcutaneous injection weekly |
| Membership | None; medication price is the whole cost |
| Insurance | Not billed; direct-pay model |
| FDA status | Compounded tirzepatide is not an FDA-approved finished product |
Embody Tirzepatide Pricing
| Compounded tirzepatide — yearly plan (sale) | $99/month |
|---|---|
| Compounded tirzepatide — monthly | $119/month |
| Compounded semaglutide — yearly plan (sale) | $49/month |
| Compounded semaglutide — monthly | $69/month |
| Shipping | Free, 1-2 days |
| Membership | None |
| Insurance | Cash-pay; not billed |
At $99/month on the yearly sale plan, Embody sits at or near the bottom of the tirzepatide market. For context, altRx bills tirzepatide month to month at $149, and MedVi sits at $297 with heavier support. Embody's number is the one to beat on price alone. The only real caveat is to confirm at checkout what the yearly plan renews to after the December 1 sale ends. Our best weight loss treatments for 2026 roundup ranks the affordable tirzepatide programs side by side.
How the Embody Tirzepatide Program Works
- 1.Complete the online intake
Answer questions on health history, weight history, and goals online. There is no in-person visit required.
- 2.A licensed clinician reviews your file
An independent licensed clinician assesses eligibility and decides whether compounded tirzepatide is clinically appropriate. A prescription is not guaranteed.
- 3.Free shipping in 1-2 days
Approved prescriptions are dispensed by a licensed pharmacy and shipped free, typically arriving within a couple of days. Tirzepatide is self-administered once weekly.
- 4.Ongoing care
Clinical follow-up is available through the program to manage titration and side effects across the dose-escalation months.
Tirzepatide: What the Evidence and the Rules Say
The clinical case for tirzepatide over semaglutide is the dual-agonist mechanism. The FDA approved tirzepatide (the active ingredient in Zepbound) for chronic weight management on the strength of the SURMOUNT trial program.
- SURMOUNT: adults on the highest dose lost roughly a fifth of their body weight alongside lifestyle changes
- That evidence base comes from branded, FDA-approved medication — not compounded preparations
- On the regulatory side, compounded tirzepatide sits in a lane that has narrowed. The FDA has clarified its policies for compounders as national GLP-1 supply stabilized, narrowing when pharmacies may produce copies of commercially available drugs — not a claim against Embody specifically, but the reason a very low price should never be the only thing you weigh.
Embody Tirzepatide Pros and Cons
Pros
- One of the lowest compounded tirzepatide prices we track, at $99/month on the yearly plan
- Semaglutide even cheaper at $49/month yearly if you want to start lower
- Free shipping that typically arrives in 1-2 days
- No membership or subscription fee stacked on the medication price
- Clinician-reviewed prescriptions, not auto-approved by an algorithm
- Fully online with no in-person visit required
Cons
- Lean service model with no coaching app or dedicated success manager
- Compounded tirzepatide is not an FDA-approved finished product and sits in a narrowing regulatory lane
- Cash-pay only; insurance is not billed
- Lowest rate needs the yearly plan and the sale ends December 1; confirm what it renews to
- No published money-back guarantee, unlike some higher-priced programs
Embody wins outright on price, so the comparison is really about what you give up for it. If you want a money-back guarantee and unlimited provider follow-ups through titration, Shed charges much more but includes both, and TrimRx adds a lifetime price lock so your rate never climbs as your dose increases. If the lowest defensible sticker is what you are after, Embody is hard to beat.
Who Embody Tirzepatide Is For
Embody tirzepatide suits the price-focused patient who wants the dual-agonist molecule and a licensed clinician behind the prescription, and who is comfortable managing titration without a heavy coaching layer. If you have taken a GLP-1 before and mostly need a clean prescription plus fast shipping at the lowest price on the board, the $99 yearly rate is the whole argument.
It is the wrong fit if you want a performance guarantee, unlimited provider messaging through the hard early weeks, or FDA-approved branded Zepbound. If semaglutide is still on your shortlist, our Embody GLP-1 review covers the $49/month yearly semaglutide plan, and for the wider category start with the weight loss treatment guide at ExploreTreatments.com.
How We Scored Embody Tirzepatide
Our 9/10 is a weighted mean of six categories, scored in August 2026 using the same criteria we apply to every GLP-1 program. Where we could not verify a claim, the category is capped rather than given full marks.
How We Scored It
Among the lowest compounded tirzepatide prices we track, with a cheaper semaglutide option and no membership fee.
Clinician-reviewed prescriptions, not auto-approved; medication is compounded and not FDA-approved.
No fees stacked on the medication price and free fast shipping.
Strong value reputation and positive reviews; no independent or trial evidence for compounded formulas.
100% online, weekly self-injection, free 1–2 day shipping.
Widely reviewed budget leader; compounded tirzepatide still sits in a narrowing regulatory lane.
The same weighted method is applied to every provider we score, so competitor ratings are comparable. See our full methodology.
Editorial Verdict
Our Editorial Take
Embody's tirzepatide offer is the clearest budget play in the category. At $99/month on the yearly plan it undercuts nearly every compounded tirzepatide program we track, and the $50 gap to its own semaglutide is smaller than the premium most platforms charge for the dual-agonist molecule. Everything you strictly need, the clinician review, the medication, and fast free shipping, is inside that price.
The trade-off is exactly what keeps the number low: this is a medication-first program, not a coaching platform, and it is compounded rather than branded. There is no published money-back guarantee, and the one detail worth confirming is what the plan renews to after the sale. Pin that down and the value is obvious.
Worth it if you want the dual-agonist molecule at the lowest defensible price and can manage your own titration. Pay more elsewhere if you want a guarantee or high-touch support through dose escalation.
Embody Tirzepatide Alternatives
For a direct comparison, see DirectMeds, Refills and Sunlight. Each of those reviews breaks down clinician oversight, how the intake works and the price you pay at renewal rather than on month one.
Recommended Providers
Our editorial team’s top picks for this category.
Embody Tirzepatide: Frequently Asked Questions
Recommended Providers
Our editorial team’s top picks for this category.
Advertising & Affiliate Disclosure: We may receive compensation when you click on links to partners featured on this site. Our rankings and recommendations are based on our independent research methodology and editorial standards, not on sponsorship or payment. Some links are affiliate links, which means we may earn a commission at no extra cost to you if you make a purchase.
Medical Disclaimer: The content on this site is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider for medical questions, treatment decisions, or emergency care. Do not disregard professional medical advice or delay seeking it based on information found here.